You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ixazomib

Showing 51 - 75 of 76
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed and/or Refractory Multiple Myeloma Trial (Ixazomib, Lenalidomide, Dexamethasone)

Terminated
Has Results
  • Relapsed and/or Refractory Multiple Myeloma
  • Ixazomib
  • +2 more
  • (no location specified)
Mar 3, 2020

Multiple Myeloma in Relapse Trial in United States (pomalidomide, ixazomib, dexamethasone)

Active, not recruiting
  • Multiple Myeloma in Relapse
  • Anchorage, Alaska
  • +335 more
Jan 10, 2022

Light-Chain Amyloidosis Trial in Worldwide (Ixazomib, Dexamethasone)

Completed
Has Results
  • Light-Chain Amyloidosis
  • Boston, Massachusetts
  • +9 more
Mar 18, 2020

Metastatic Renal Cell Carcinoma, RCC Trial in Philadelphia (Ixazomib, Pegylated IFN-alpha 2b)

Terminated
Has Results
  • Metastatic Renal Cell Carcinoma
  • RCC
  • Ixazomib
  • Pegylated IFN-alpha 2b
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Sep 25, 2019

Follicular Lymphoma Trial in Worldwide (IXAZOMIB)

Completed
Has Results
  • Follicular Lymphoma
  • IXAZOMIB
  • Boston, Massachusetts
  • +13 more
Oct 7, 2019

Multiple Myeloma Trial in United Kingdom (Ixazomib, Cyclophosphamide, Dexamethasone)

Unknown status
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Birmingham, United Kingdom
  • +17 more
Jan 21, 2020

Advanced Non-hematologic Malignancies Trial in Canada, United States (IXAZOMIB)

Completed
Has Results
  • Advanced Non-hematologic Malignancies
  • IXAZOMIB
  • Tampa, Florida
  • +6 more
Jul 30, 2019

Multiple Myeloma Trial in Worldwide (bb2121, Daratumumab, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +8 more
  • Birmingham, Alabama
  • +59 more
Dec 13, 2022

Multiple Myeloma Trial in Austria, Czechia, Germany (Ixazomib, Thalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Linz, Oberösterreich, Austria
  • +16 more
Dec 12, 2019

Relapsed and Refractory Multiple Myeloma Trial in United States (Ixazomib)

Completed
Has Results
  • Relapsed and Refractory Multiple Myeloma
  • Ixazomib
  • Tampa, Florida
  • +4 more
Jun 19, 2019

Solitary Osseous Plasmacytoma Trial in United States (ixazomib, lenalidomide, dexamethasone)

Active, not recruiting
  • Solitary Osseous Plasmacytoma
  • ixazomib
  • +3 more
  • Anchorage, Alaska
  • +387 more
Aug 16, 2021

Multiple Myeloma Trial in Worldwide (Cyclophosphamide, Ixazomib, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Hazard, Kentucky
  • +23 more
Jun 24, 2019

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma, t(11;14) Negative Trial (Dexamethasone, Ixazomib, Ixazomib

Withdrawn
  • Recurrent Plasma Cell Myeloma
  • +2 more
  • (no location specified)
Mar 25, 2019

Multiple Myeloma, Advanced Solid Tumors Trial in Canada, United States (Ixazomib)

Completed
Has Results
  • Multiple Myeloma
  • Advanced Solid Tumors
  • Ixazomib
  • Atlanta, Georgia
  • +10 more
Mar 8, 2019

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Terminated
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +14 more
  • Ixazomib
  • Stanford, California
    Stanford University Cancer Institute
Apr 1, 2019

Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Berkeley, California
  • +19 more
Mar 20, 2019

Lupus Nephritis Trial in Worldwide (Ixazomib, Placebo)

Terminated
Has Results
  • Lupus Nephritis
  • Ixazomib
  • Placebo
  • La Jolla, California
  • +34 more
Jan 11, 2019

Multiple Myeloma Trial in Hong Kong, Korea, Republic of, Singapore (Ixazomib, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Pokfulam, Hong Kong
  • +4 more
Mar 20, 2018

Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Cleveland (ixazomib, mitoxantrone HCl,

Completed
  • Recurrent Adult Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • ixazomib
  • +3 more
  • Cleveland, Ohio
  • +1 more
Dec 12, 2018

Leukemia Trial in Houston (Ixazomib)

Terminated
Has Results
  • Leukemia
  • Ixazomib
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 2, 2018

Acute Lymphoblastic Leukemia in Complete Remission, Lymphoblastic Lymphoma in Complete Remission, Mixed Phenotype Acute Leukemia

Withdrawn
  • Acute Lymphoblastic Leukemia in Complete Remission
  • +2 more
  • Ixazomib
  • Milwaukee, Wisconsin
    Froedtert & the Medical College of Wisconsin
Feb 13, 2018

Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Scottsdale, Arizona
  • +15 more
Mar 12, 2018

Multiple Myeloma Trial in Worldwide (Ixazomib, Melphalan, Prednisone)

Completed
Has Results
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Lebanon, New Hampshire
  • +19 more
Dec 22, 2017

Multiple Myeloma Trial in Little Rock (Ixazomib, Pomalidomide, Dexamethasone)

Withdrawn
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Little Rock, Arkansas
    University of Arkansas for Medical Science
Jan 20, 2017

Advanced Solid Tumors, Hematologic Malignancies Trial in United States (IXAZOMIB)

Completed
Has Results
  • Advanced Solid Tumors
  • Hematologic Malignancies
  • IXAZOMIB
  • Fairway, Kansas
  • +3 more
May 3, 2016